Heron Therapeutics
HRTX
#7927
Rank
NZ$0.43 B
Marketcap
$2.88
Share price
0.31%
Change (1 day)
-24.62%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.06. In 2022 the company made an earnings per share (EPS) of -$3.05 an increase over its 2021 EPS that were of -$3.97.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-36.5%
2022-$3.05-23.11%
2021-$3.97-10%
2020-$4.41-0%
2019-$4.411.21%
2018-$4.36-32.7%
2017-$6.47-19.34%
2016-$8.0254.76%
2015-$5.181.73%
2014-$5.10-16.23%
2013-$6.0891.67%
2012-$3.17-31.45%
2011-$4.63-27.06%
2010-$6.35-43.75%
2009-$11.28-57.33%
2008-$26.45-82.92%
2007-$154.8120.61%
2006-$128.36175.76%
2005-$46.55-21.43%
2004-$59.24100%
2003-$29.62-38.24%
2002-$47.96161.54%
2001-$18.34-106.46%
2000$283.692051.55%
1999$13.19839.73%
1998$1.40-105.48%
1997-$25.62-88.16%
1996-$216.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.29-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.25-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.87 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.77-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.91 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA